Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Menée sur un modèle animal (poisson zèbre) de neuroblastome, cette étude met en évidence le rôle d'une activation du gène ALK, associée à une amplification de MYCN, dans la pathogenèse de ce cancer
Amplification of the MYCN oncogene in childhood neuroblastoma is often accompanied by mutational activation of ALK (anaplastic lymphoma kinase), suggesting their pathogenic cooperation. We generated a transgenic zebrafish model of neuroblastoma in which MYCN-induced tumors arise from a subpopulation of neuroblasts that migrate into the adrenal medulla analog following organogenesis. Coexpression of activated ALK with MYCN in this model triples the disease penetrance and markedly accelerates tumor onset. MYCN overexpression induces adrenal sympathetic neuroblast hyperplasia, blocks chromaffin cell differentiation, and ultimately triggers a developmentally-timed apoptotic response in the hyperplastic sympathoadrenal cells. Coexpression of activated ALK with MYCN provides prosurvival signals that block this apoptotic response and allow continued expansion and oncogenic transformation of hyperplastic neuroblasts, thus promoting progression to neuroblastoma. º Zebrafish neuroblastomas closely reiterate the pathogenesis of human neuroblastomas º ALK accelerates MYCN-induced neuroblastoma onset and increases disease penetrance º MYCN induces aberrant neuroblast hyperplasia and developmentally-timed apoptosis º ALK mediates hyperplastic neuroblast survival to promote MYCN-induced neuroblastoma
Cancer cell , article en libre accès, 2011